New York, November 16, 2006 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: SW CRX) today presents an update on the Company's strategy, organization, product sales, research and development programs, and financial outlook in a meeting with analysts and investors held in New York. A live audio webcast of the meeting, featuring the presentation slides, can be accessed via the homepage of Crucell's website at www.crucell.com, and will be archived and available for replay following the event.
